Research
Pioneering the Future of Non-Invasive Health Diagnostics
At ReMinded, we are redefining the way mental health and physiological conditions are detected, monitored, and understood. Powered by a decade of scientific innovation, our novel biosensor technology enables real-time, non-invasive measurement of critical biomarkers
— starting with cortisol, the body’s key stress hormone.
At the heart of ReMinded’s innovation is the groundbreaking research of our Chief Scientific Officer, Dr. Sanjida Yeasmin, whose PhD work in biosensor technology led to the development of our proprietary, saliva-based molecular sensing platform. Unlike traditional laboratory methods that require blood draws, bulky equipment, and long processing times, our biosensor delivers lab-level accuracy (97% correlation with LC-MS standards) within minutes, through a simple, painless saliva sample.
Our first clinical focus is cortisol detection for mental health and stress-related applications — but this is just the beginning. Our technology is designed for expansion to a broad panel of biomarkers, including serotonin, estrogen, testosterone, CRP, dopamine, cardiac troponin, glucose, and even drug levels — unlocking applications across mental health, hormone health, cardiovascular care, and addiction treatment.
Our Technology: A New Golden Standard
Traditional point-of-care devices often sacrifice accuracy for convenience. ReMinded is different.
Using electrochemical biosensors — a detection method engineered to achieve unprecedented sensitivity and selectivity — our biosensor achieves results comparable to the industry “gold standard” (LC-MS) without the need for complex lab infrastructure. Unlike antibody or aptamer-based systems, which are fragile and highly sensitive to pH and temperature, our device is optimized for the natural variability of saliva samples, ensuring consistent, accurate measurements in real-world conditions.
Collaboration at the Core
Scientific progress does not happen in isolation. At ReMinded, we embrace multidisciplinary collaboration, uniting neuroscience, biosensor technology, clinical expertise, and patient-centered design to drive lasting impact. Our team’s partnerships with leading clinical institutions, alongside our collaborations with top-tier vendors like Linxens for screen-printed electrodes and PalmSens for portable readers, ensure that the solutions we bring to market are both scientifically rigorous and deeply human-centered.
